Archives for January 22, 2013

← 2013

USPLabs sets aside $2m to settle DMAA class action cases

By Elaine WATSON

After a tidal wave of lawsuits and months of heated debate about the regulatory status of the stimulant DMAA (1,3-Dimethylamylamine), USPLabs has agreed to settle a nationwide class action suit challenging the legality and safety of its top-selling DMAA...

Letter to the editor

Comment is free, but fact is sacred: The 3 macular carotenoids are required to enrich macular pigment and optimise vision

By Dr. John Nolan and Prof. Stephen Beatty - Macular Pigment Research Group, Vision Research Centre, Waterford, Ireland

Claims that meso-zeaxanthin is not required for eye health formulations in addition to the established ingredients, lutein and zeaxanthin, are "misleading" and "erroneous", leading eye-health researchers tell NutraIngredients.